ABSTRACT Tissue inhibitor of metalloproteinases (TIMP) and collagenase inhibitory activity were measured in the sputum from nine subjects with chronic bronchitis before and five days after treatment with corticosteroid (oral prednisolone, 40mg daily). The mean sputum TIMP concentrations for eight of the nine subjects increased from 3-1 (SD 0-87) ,ug/ml to 5-8 (1 9) ,ug/ml (2p < 0005). Similarly, the mean collagenase inhibitory activity in the sputum of eight of the nine subjects increased from 1 53 (1 1) U/ml to 2 69 (092) U/ml (2p < 0 05). The TIMP concentrations in sputum exceeded the collagenase inhibitory activity, suggesting that a proportion of the TIMP was inactive. TIMP inactivity was not due to prior complexing with enzyme since the molecular weight of sputum TIMP (27 500) was similar to that described for the purified protein (28 000-28 500). Preliminary studies showed the presence of TIMP in bronchoalveolar lavage samples (range of six specimens 045 ng/ml-2.1 jug/ml, median 53 ng/ml). Collagenase inhibitory activity was detected in only two of these six lavage samples, suggesting that the TIMP was totally inactive in the other four samples. The significance of the metalloproteinase-inhibitor balance in the pathogenesis of chronic lung disease requires further study.
The pathogenesis of acute and chronic lung diseases is poorly understood but evidence suggests that proteolytic enzymes derived from leucocytes or pathogens play a part in causing lung destruction.' 2 The "proteinase-antiproteinase" theory of lung disease proposes that the proteinase inhibitors of the normal lung prevent tissue digestion by extracellular proteinases. Should the proteinases overwhelm the inhibitors, however, tissue destruction occurs.
Specifically, neutrophil serine elastase activity is thought to be important in the pathogenesis of emphysema since (a) elastases cause, in experimental animals, pathological changes characteristic of emphysema3 and (b) inherited deficiency of a, antitrypsin, the major serum inhibitor of serine proteinases, is associated with the early development of Nine subjects (six of them men) with chronic obstructive bronchitis were studied while in hospital for the assessment of a trial of corticosteroid treatment (40 mg oral prednisone daily). All patients were studied at least four weeks after any infective episode. Their mean age was 53 (SD 7 8) years and the range 46-64. The mean FEV1/FVC was 42-9% (SD 11 7%). All were current smokers. Sputum was collected during four hours early morning, as above for several days while the patients were having placebo treatment and then on each day of steroid treatment. Sputum from each patient collected on the last day of placebo treatment and the fifth day of corticosteroid treatment was assayed for TIMP concentration and collagenase inhibitory activity. Differences in TIMP and collagenase inhibitory activity were analysed with Student's t test for paired data.
BRONCHOALVEOLAR LAVAGE SAMPLES
TIMP and collagenase inhibitory activity were measured (as above) in bronchoalveolar lavage samples obtained from six further subjects who were undergoing fibreoptic bronchoscopy in the investigation of suspected neoplasia. The radiographically normal lung was lavaged; premedication consisted of 600 ig atropine sulphate intramuscularly and 5-10mg diazepam intravenously. Lignocaine was used for topical anaesthesia and the bronchoscope was wedged in the middle lobe or lingula. A total of 120 ml of physiological saline was instilled in six aliquots, each aliquot being aspirated by gentle suction before introduction of the next one. Excess mucus was removed by filtering the lavage fluid through gauze and cells were removed by centrifugation at 400g. The lavage samples were concentrated fivefold by ultrafiltration and stored at -70°C until they were analysed.
GEL FRACTIONATION OF SPUTUM
A pool of mucoid sputum (10 ml) was applied to a 59 742 macia). Blue dextran and cytochrome c were added to the sputum as reference substances for column calibration. The column was eluted with 01 mol/l Tris/HCI buffer, pH 8-0, containing 0.5 mol/I NaCl at a rate of 36 mi/h and 6 ml fractions were collected. Blue dextran and cytochrome c concentrations in the fractions were determined by spectrophotometry at 615 and 413 nm respectively. TIMP concentrations in the fractions were measured as above, a, antitrypsin and antileucoprotease by enzyme linked immunosorbent assay,16 and albumin by rocket immunoelectrophoresis.
The column elution curves were plotted for blue dextran and the above proteins. The curves were triangulated to give peak elution volume (Ve) and the column was calibrated on the basis of the known molecular weight of the reference proteins-namely, TIMP and collagenase inhibitory activity were detected in all sputum samples collected from the six subjects over five consecutive days. The TIMP values ranged from 1 0 to 7-2pg/ml (mean 3-76, SD 1-5 pg/ml). The average value for each day was relatively constant. The between subject coefficient of variation on each day ranged from 18X1% to 63% (mean 33-8%). The within patient coefficient of variation over the five days ranged from 22-5% to 53-7% (mean 37 4%).
The collagenase inhibitory activity in the sputum from the six subjects over the five days ranged from 0-9 to 12-4 U/ml (mean 2-70 (SD 2 1) U/mi). The between subject coefficient of variation on each day ranged from 24f9% to 105-3% (mean 58 6%). The within patient coefficient of variation over the five days for collagenase inhibitory activity ranged from 6-3% to 84-3% (mean 28 4% TIMP was present in the sputum from all nine patients with chronic bronchitis before and after corticosteroid treatment. The mean concentration before treatment was 3 1 (SD 0-87) jg/ml.
The sputum TIMP concentration increased in eight (fig 1) of the nine patients after five days' treatment (mean 5-8 (SD 1 9) jg/ml; 2p < 0 005). Collagenase inhibitory activity was observed in seven of the nine sputum samples before corticosteroid treatment (mean 1 53 (1 1) U/ml) and was present in all samples after five days' treatment (mean 2-69 (0.92) U/ml), having increased in eight of the nine patients (fig 1) . Statistical analysis of the data for all nine subjects showed the results to be significant (2p < 0 005).
BRONCHOALVEOLAR LAVAGE SAMPLES
TIMP was detected in all six bronchoalveolar lavage samples studied, the range of values being 0 45 ng/ml-2-1 Mg/ml (median 53 ng/ml). Collagenase inhibitory activity was observed in only two of the six samples (0-17 and 0-75 U/ml).
COMPARISON OF TIMP AND COLLAGENASE INHIBITORY ACTIVITY
In the assay system described here 4-2 U/ml of collagenase inhibitory activity represents the potential inhibitory activity of 1 mg/ml purified TIMP. The mean collagenase inhibitory activity of all the sputum samples collected (n = 48 from variability and corticosteroid studies combined) when calculated from the TIMP concentrations is 16 9 (SD 7 5) U/ml; but the measured collagenase inhibitory activities in the samples were less than would be predicted from the TIMP concentrations, with a mean of 2 5 (1 8) U/ml. Similarly, the collagenase inhibitory activities of the bronchoalveolar lavage samples were lower than would be predicted from the amount of TIMP present and four of the lavage specimens showed no apparent inhibitory activity despite the presence of TIMP.
MOLECULAR WEIGHT OF SPUTUM TIMP
After the gel filtration of sputum on Sephacryl S300 TIMP was detected in fractions representing a single elution peak (fig 2) . The calculated molecular weight of the sputum TIMP was 27 500.
Discussion
Human lung secretions have been reported to contain metalloproteinase activity.5`8 The role of these enzymes in contributing to connective tissue damage associated with chronic obstructive lung disease remains obscure; their action would depend on disturbance of the usual balance between the extracellular release of the enzymes and their inhibitors. The nature of metalloproteinase inhibitors in the lung secretions has not been investigated, although a2 macroglobulin, a potential inhibitor of these 17 _i enzymes, is present in sputum'" and bronchoalveolar lavage samples.'9 The a2 macroglobulin, in lung secretions, is, however, largely derived from the blood by transudation"8 and, since it is a large protein, secretion concentrations are relatively low.
TIMP appears to be a major inhibitor of metalloproteinases in connective tissues'0 and the present study shows that this protein is present in most sputum samples from patients with chronic obstructive bronchitis. Similarly, most of the samples showed the ability to inhibit metalloproteinase activity. The daily variation of sputum TIMP and collagenase inhibitory activity were similar to that described for other proteins.20
The theoretical capacity of the observed sputum TIMP to inhibit the collagenase activity in our assay system exceeded the actual inhibitory capacity of the samples as determined by comparison with the specific activity of the pure TIMP we used for standardisation. Sputum metalloproteinase inhibitors 744 other than TIMP would be present; but even so the results suggest that the TIMP in the secretions was not fully active. This conclusion is supported by the absence of collagenase inhibitory capacity in some samples that were shown immunologically to contain TIMP. There are several possible explanations for this observation. Firstly, the specific activity of "lung" TIMP may differ from that of the purified protein. Secondly, since TIMP inhibits metalloproteinases by the formation of stable complexes,21 a proportion of the sputum TIMP may be in the form of inhibitor-enzyme complexes. The results from the gel filtration of sputum, however, suggested that the TIMP was largely in its native molecular form and not complexed. Thirdly, the sputum TIMP may be altered or inactivated by proteolytic cleavage in a manner perhaps similar to that described for a, antitrypsin.' 2 Nothing is currently known about this potential mechanism with regard to TIMP but the calculated molecular weight of TIMP in sputum was 27 500, a value similar to that reported for the active purified protein (28 000-28 500).1214 The difference in molecular weight of only 500-1000 might represent limited proteolysis of sputum TIMP, but such a small difference could also be explained by the varying accuracy of the techniques for estimation of molecular weight. Other mechanisms for inactivation of TIMP may exist. For instance, the serine proteinase inhibitor a, antitrypsin (al proteinase inhibitor) is inactivated if a methionine residue at its active site is oxidised. 22 The active site of TIMP, however, is not yet characterised and the effects of oxidants are unknown. Further studies on TIMP derived from the lung will be necessary to explain why it is less effective than expected at inhibiting metalloproteinases. Nevertheless, the results of the two assays moved in parallel and do indicate that the balance between metalloproteinases and their inhibitors in sputum from patients with chronic bronchitis usually favours the inhibitors.
The source of TIMP in lung secretions is likely to include fibroblasts,'0 1" epithelial cells,10 and macrophages. ' 23 The present study has shown that corticosteroids increase the capacity of sputum to inhibit collagenase. In parallel, TIMP concentrations in sputum were increased. Thus, although corticosteroids may have resulted in reduced extracellular release of metalloproteinases, the increased collagenase inhibition does appear to reflect an increased concentration of TIMP in the secretions. The reasons for the increased TIMP concentration and collagenase inhibitory activity in the sputum of patients receiving corticosteroids are not clear. Possibly corticosteroids reduced the volume or degree of hydration of the lung secretions. Alternatively, the steroid treatment may have directly stimulated TIMP synthesis by lung tissues. This hypothesis is supported by the observation that corticosteroids can increase the production of TIMP as well as reducing collagenase secretion by connective tissues in vitro.'3 Further studies will be required, but these results suggest a beneficial effect of corticosteroids in increasing the concentration of metalloproteinase inhibitor in lung secretions.
Studies of sputum do not fully clarify the role of TIMP at the bronchoalveolar level, where the release of metalloproteinase could have a role in the development of emphysema. We therefore performed a preliminary study of the TIMP concentration and collagenase inhibitory activity in bronchoalveolar lavage samples from six patients undergoing diagnostic bronchoscopy for carcinoma of the bronchus. TIMP was detected in all but collagenase inhibitory activity was observed in only two of the six lavage samples. These results indicate that bronchoalveolar lavage fluid also contains inactive TIMP, and further studies of the balance between metalloproteinases and their inhibitors in the lower respiratory tract are clearly indicated. It would also be fruitful to investigate the major source or sources of TIMP and collagenase in the lung by their immunolocalisation in pulmonary tissue.
